Pfizer Inc. (PFE.F)
EUR 25.0
(-0.48%)
EUR 25.0
(-0.48%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 9.55 Billion USD | -66.89% |
| 2022 | 43.63 Billion USD | 52.94% |
| 2021 | 30.79 Billion USD | 102.85% |
| 2020 | 13.26 Billion USD | -28.77% |
| 2019 | 18.64 Billion USD | -7.78% |
| 2018 | 11.06 Billion USD | 5.81% |
| 2017 | 19.84 Billion USD | 6.09% |
| 2016 | 19.07 Billion USD | 7.82% |
| 2015 | 17.69 Billion USD | -8.0% |
| 2014 | 19.13 Billion USD | -12.29% |
| 2013 | 23.54 Billion USD | -12.46% |
| 2012 | 25.04 Billion USD | -14.15% |
| 2011 | 29.17 Billion USD | 26.58% |
| 2010 | 23.04 Billion USD | 2.37% |
| 2009 | 22.51 Billion USD | -14.19% |
| 2008 | 15.3 Billion USD | 48.28% |
| 2007 | 17.69 Billion USD | -16.8% |
| 2006 | 21.26 Billion USD | -11.98% |
| 2005 | 24.16 Billion USD | -3.87% |
| 2004 | 25.13 Billion USD | 11.75% |
| 2003 | 22.49 Billion USD | 61.49% |
| 2002 | 13.92 Billion USD | 7.43% |
| 2001 | 12.96 Billion USD | 2.09% |
| 2000 | 12.69 Billion USD | 144.59% |
| 1999 | 5.19 Billion USD | 1.78% |
| 1998 | 5.1 Billion USD | 24.23% |
| 1997 | 4.1 Billion USD | 8.45% |
| 1996 | 3.78 Billion USD | 18.49% |
| 1995 | 3.19 Billion USD | 34.51% |
| 1994 | 2.37 Billion USD | 110.8% |
| 1993 | 1.12 Billion USD | -25.49% |
| 1992 | 1.51 Billion USD | -9.83% |
| 1991 | 1.67 Billion USD | 52.95% |
| 1990 | 1.09 Billion USD | -0.4% |
| 1989 | 1.1 Billion USD | 6.69% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 6.34 Billion USD | 299.93% |
| 2024 Q2 | 4.39 Billion USD | -59.54% |
| 2023 Q4 | 1.48 Billion USD | 285.18% |
| 2023 FY | - USD | -66.89% |
| 2023 Q1 | 8.39 Billion USD | 11.03% |
| 2023 Q2 | 4.21 Billion USD | -49.86% |
| 2023 Q3 | -803 Million USD | -119.07% |
| 2022 FY | - USD | 52.94% |
| 2022 Q3 | 11.32 Billion USD | -17.11% |
| 2022 Q4 | 7.56 Billion USD | -33.22% |
| 2022 Q2 | 13.66 Billion USD | 18.57% |
| 2022 Q1 | 11.52 Billion USD | 106.91% |
| 2021 Q4 | 5.56 Billion USD | -40.51% |
| 2021 Q3 | 9.36 Billion USD | 27.43% |
| 2021 FY | - USD | 102.85% |
| 2021 Q1 | 6.29 Billion USD | 161.96% |
| 2021 Q2 | 7.34 Billion USD | 16.68% |
| 2020 Q2 | 4.77 Billion USD | -11.09% |
| 2020 Q4 | 2.4 Billion USD | -46.24% |
| 2020 Q1 | 5.37 Billion USD | 69.63% |
| 2020 FY | - USD | -28.77% |
| 2020 Q3 | 4.47 Billion USD | -6.45% |
| 2019 FY | - USD | -7.78% |
| 2019 Q1 | 6.13 Billion USD | 28.65% |
| 2019 Q2 | 5.7 Billion USD | -6.97% |
| 2019 Q3 | 4.74 Billion USD | -16.76% |
| 2019 Q4 | 3.16 Billion USD | -33.26% |
| 2018 Q2 | 5.25 Billion USD | -2.52% |
| 2018 Q3 | 5.18 Billion USD | -1.29% |
| 2018 Q4 | 4.76 Billion USD | -8.14% |
| 2018 Q1 | 5.39 Billion USD | 38.16% |
| 2018 FY | - USD | 5.81% |
| 2017 Q4 | 3.9 Billion USD | -27.65% |
| 2017 Q1 | 5.54 Billion USD | 54.74% |
| 2017 Q3 | 5.39 Billion USD | 0.04% |
| 2017 Q2 | 5.39 Billion USD | -2.85% |
| 2017 FY | - USD | 6.09% |
| 2016 Q2 | 5.08 Billion USD | -6.89% |
| 2016 Q4 | 3.58 Billion USD | -27.28% |
| 2016 Q3 | 4.93 Billion USD | -3.03% |
| 2016 FY | - USD | 7.82% |
| 2016 Q1 | 5.46 Billion USD | 66.24% |
| 2015 FY | - USD | -8.0% |
| 2015 Q1 | 4.31 Billion USD | 18.27% |
| 2015 Q2 | 4.94 Billion USD | 14.5% |
| 2015 Q3 | 5.15 Billion USD | 4.21% |
| 2015 Q4 | 3.28 Billion USD | -36.23% |
| 2014 FY | - USD | -12.29% |
| 2014 Q1 | 4.97 Billion USD | -4.55% |
| 2014 Q3 | 5.1 Billion USD | -5.41% |
| 2014 Q4 | 3.65 Billion USD | -28.45% |
| 2014 Q2 | 5.39 Billion USD | 8.49% |
| 2013 Q4 | 5.2 Billion USD | -8.15% |
| 2013 Q3 | 5.67 Billion USD | -2.29% |
| 2013 Q2 | 5.8 Billion USD | -2.86% |
| 2013 Q1 | 5.97 Billion USD | 4.15% |
| 2013 FY | - USD | -12.46% |
| 2012 FY | - USD | -14.15% |
| 2012 Q2 | 6.15 Billion USD | -27.41% |
| 2012 Q1 | 8.47 Billion USD | 40.57% |
| 2012 Q4 | 5.73 Billion USD | -14.98% |
| 2012 Q3 | 6.74 Billion USD | 9.62% |
| 2011 FY | - USD | 26.58% |
| 2011 Q4 | 6.03 Billion USD | -4.06% |
| 2011 Q3 | 6.28 Billion USD | 4.18% |
| 2011 Q2 | 6.03 Billion USD | -3.93% |
| 2011 Q1 | 6.28 Billion USD | 40.95% |
| 2010 Q4 | 4.45 Billion USD | 24.01% |
| 2010 FY | - USD | 2.37% |
| 2010 Q1 | 6.14 Billion USD | 35.24% |
| 2010 Q3 | 3.59 Billion USD | -49.76% |
| 2010 Q2 | 7.15 Billion USD | 16.35% |
| 2009 Q2 | 4.55 Billion USD | -17.11% |
| 2009 Q3 | 4.95 Billion USD | 8.81% |
| 2009 Q4 | 4.54 Billion USD | -8.18% |
| 2009 Q1 | 5.48 Billion USD | -41.93% |
| 2009 FY | - USD | -14.19% |
| 2008 Q1 | 5.53 Billion USD | 25.77% |
| 2008 Q3 | 6.11 Billion USD | 19.14% |
| 2008 Q4 | 9.45 Billion USD | 54.51% |
| 2008 FY | - USD | 48.28% |
| 2008 Q2 | 5.13 Billion USD | -7.14% |
| 2007 Q1 | 6.71 Billion USD | 29.44% |
| 2007 Q3 | 2.39 Billion USD | -42.74% |
| 2007 Q4 | 4.39 Billion USD | 83.36% |
| 2007 Q2 | 4.18 Billion USD | -37.59% |
| 2007 FY | - USD | -16.8% |
| 2006 Q3 | 5.1 Billion USD | -3.13% |
| 2006 Q4 | 5.18 Billion USD | 1.55% |
| 2006 FY | - USD | -11.98% |
| 2006 Q1 | 5.84 Billion USD | 4.11% |
| 2006 Q2 | 5.27 Billion USD | -9.85% |
| 2005 Q3 | 6.63 Billion USD | 29.61% |
| 2005 FY | - USD | -3.87% |
| 2005 Q1 | 6.79 Billion USD | -5.65% |
| 2005 Q2 | 5.11 Billion USD | -24.68% |
| 2005 Q4 | 5.61 Billion USD | -15.33% |
| 2004 Q3 | 6.16 Billion USD | 21.83% |
| 2004 FY | - USD | 11.75% |
| 2004 Q4 | 7.2 Billion USD | 16.86% |
| 2004 Q2 | 5.05 Billion USD | -39.45% |
| 2004 Q1 | 8.35 Billion USD | 30.94% |
| 2003 FY | - USD | 61.49% |
| 2003 Q4 | 6.38 Billion USD | 65.8% |
| 2003 Q3 | 3.84 Billion USD | -52.86% |
| 2003 Q2 | 8.16 Billion USD | 100.71% |
| 2003 Q1 | 4.06 Billion USD | 7.74% |
| 2002 Q2 | 2.98 Billion USD | -14.74% |
| 2002 Q3 | 3.66 Billion USD | 22.68% |
| 2002 FY | - USD | 7.43% |
| 2002 Q4 | 3.77 Billion USD | 3.09% |
| 2002 Q1 | 3.5 Billion USD | 6.12% |
| 2001 Q2 | 3.12 Billion USD | -5.77% |
| 2001 Q3 | 3.23 Billion USD | 3.65% |
| 2001 Q4 | 3.29 Billion USD | 2.01% |
| 2001 FY | - USD | 2.09% |
| 2001 Q1 | 3.31 Billion USD | 6.53% |
| 2000 Q4 | 3.1 Billion USD | 2.74% |
| 2000 Q1 | 2.37 Billion USD | -2.38% |
| 2000 Q2 | 2.5 Billion USD | 74.97% |
| 2000 Q3 | 3.02 Billion USD | 20.57% |
| 2000 FY | - USD | 144.59% |
| 1999 Q3 | 1.2 Billion USD | -2.11% |
| 1999 Q4 | 1.46 Billion USD | 22.01% |
| 1999 FY | - USD | 1.78% |
| 1999 Q1 | 1.29 Billion USD | -3.01% |
| 1999 Q2 | 1.23 Billion USD | -4.73% |
| 1998 Q4 | 1.33 Billion USD | -7.57% |
| 1998 Q3 | 1.44 Billion USD | 22.03% |
| 1998 Q2 | 1.18 Billion USD | 8.66% |
| 1998 FY | - USD | 24.23% |
| 1998 Q1 | 1.08 Billion USD | 6.26% |
| 1997 FY | - USD | 8.45% |
| 1997 Q4 | 1.02 Billion USD | -5.89% |
| 1997 Q1 | 1.11 Billion USD | 11.87% |
| 1997 Q3 | 1.08 Billion USD | 22.3% |
| 1997 Q2 | 888 Million USD | -20.14% |
| 1996 Q1 | 967 Million USD | 10.05% |
| 1996 Q3 | 1.02 Billion USD | 50.44% |
| 1996 Q2 | 680 Million USD | -29.68% |
| 1996 Q4 | 994 Million USD | -2.83% |
| 1996 FY | - USD | 18.49% |
| 1995 Q1 | 746.5 Million USD | 6.43% |
| 1995 FY | - USD | 34.51% |
| 1995 Q2 | 626.9 Million USD | -7.86% |
| 1995 Q4 | 878.7 Million USD | 4.45% |
| 1995 Q3 | 841.3 Million USD | 22.32% |
| 1994 Q1 | 637.9 Million USD | 161.28% |
| 1994 Q3 | 572.8 Million USD | 23.26% |
| 1994 Q2 | 464.7 Million USD | -27.15% |
| 1994 FY | - USD | 110.8% |
| 1994 Q4 | 701.4 Million USD | 22.45% |
| 1993 Q4 | -278.6 Million USD | -182.54% |
| 1993 Q2 | 799.8 Million USD | 40.69% |
| 1993 FY | - USD | -25.49% |
| 1993 Q3 | 1.26 Billion USD | 57.68% |
| 1993 Q1 | 568.5 Million USD | 62.99% |
| 1992 Q4 | 348.8 Million USD | -22.35% |
| 1992 Q2 | 259.6 Million USD | -42.93% |
| 1992 Q3 | 449.2 Million USD | 73.04% |
| 1992 FY | - USD | -9.83% |
| 1992 Q1 | 454.9 Million USD | -21.43% |
| 1991 Q2 | 278.7 Million USD | -31.66% |
| 1991 FY | - USD | 52.95% |
| 1991 Q4 | 579 Million USD | 40.47% |
| 1991 Q3 | 434.8 Million USD | 47.9% |
| 1991 Q1 | 407.8 Million USD | 79.02% |
| 1990 Q1 | 285 Million USD | 108.88% |
| 1990 Q4 | 227.8 Million USD | -34.62% |
| 1990 Q3 | 348.4 Million USD | 47.25% |
| 1990 Q2 | 265.2 Million USD | -16.98% |
| 1990 FY | - USD | -0.4% |
| 1989 FY | - USD | 6.69% |
| 1989 Q3 | 1.43 Billion USD | 10.42% |
| 1989 Q2 | 1.3 Billion USD | -9.3% |
| 1989 Q1 | 1.43 Billion USD | 147.79% |
| 1989 Q4 | -3.2 Billion USD | -323.1% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Bayer Aktiengesellschaft | 4.2 Billion EUR | -127.061% |
| Sanofi | 11.99 Billion EUR | 20.338% |